Concepedia

Chandrashekhar Dasari

CD

Statistics

Publications

11

Citations

282

H-Index

10

Active since

2017

Affiliations

Indian Institute of Chemical Technology(Current)

Academy of Scientific and Innovative Research

University of California, San Francisco

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, Berkeley

Chandrashekhar Dasari is an author at Indian Institute of Chemical Technology specializing in oncology, life sciences, and prostate cancer.

ORCID

Publications per year

2017–2025

11

Publications

11

Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA)

Karthik Reddy Kami Reddy, Chandrashekhar Dasari, Divya Duscharla et al. · Angiogenesis · 2017 · 80 citations

, , +12

Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy

Anil P. Bidkar, Sinan Wang, Kondapa Naidu Bobba et al. · Clinical Cancer Research · 2023 · 49 citations · Full text

, , +17

Interleukin‐6 induced overexpression of valosin‐containing protein (VCP)/p97 is associated with androgen‐independent prostate cancer (AIPC) progression

Divya Duscharla, Karthik Reddy Kami Reddy, Chandrashekhar Dasari et al. · Journal of Cellular Physiology · 2018 · 31 citations

, , +17

Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration

Chandrashekhar Dasari, Karthik Reddy Kami Reddy, Sirisha Natani et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2019 · 21 citations

, , +12

Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells

Chandrashekhar Dasari, Dattu Prasad Yaghnam, Reinhard Walther et al. · Tumor Biology · 2017 · 20 citations · Full text

, , +17

1–5 of 11